Vous êtes sur la page 1sur 3

GW 501516

Posted on October 15, 2013 by Maxim Peptide


GW501516 is a peptide that is considered to be a PPAR receptor agonist. It is occasionally known as GW
501!516! GW1516! G"#516! and $nd%robol.
&echanics o' GW501516
According to scienti'ic research cond%cted on ani(al test s%b)ects!
GW501516 acti*ates si(ilar pathways that are acti*ated thro%gh
e+ercise. ,ne o' these pathways is PPAR! also known as
Pero+iso(e proli'eratoracti*ated receptor delta. -his pathway is a
n%clear hor(one receptor in ani(al test s%b)ects that r%les o*er a
host o' biological processes and (ay ha*e a role in *ario%s chronic
diseases s%ch as obesity! atherosclerosis! diabetes! and cancer. It is
belie*ed to work at the gene le*el and a''ects the (etabolis( o'
skeletal (%scle Another one o' the pathways the peptide acti*ates is
A&Pacti*ated protein kinase! which is an en.y(e that plays a role in
cell%lar energy ho(eostasis in ani(al test s%b)ects.
GW50156 acts as a selecti*e acti*ator o' the PPAR receptor
beca%se it shows high a''inity and potency 'or the pathway. In ani(al
test s%b)ects s%ch as rats! the binding o' the peptide to this partic%lar
receptor recr%its the coacti*ator PG/10. In t%rn! this coacti*ator
%preg%lates the e+pression o' proteins associated with energy
e+p%lsion. -his! in t%rn! led to the scienti'ic theory that the peptide
co%ld increase (%sc%lar strength and end%rance in ani(al test
s%b)ects. Addtionally! the peptide showed an ability to ele*ate 'atty
acid (etabolis( in skeletal (%scle 'or (eans o' protection against dietind%ced obesity! as well as an increase in
gl%cose %ptake in skeletal (%scle tiss%e and an ele*ation in gene e+pression. 1%rther(ore scienti'ic research
based on ani(al test s%b)ects deter(ined that the peptide co%ld ca%se an increased b%rning o' 'at witho%t
e+periencing (%scle catabolis(2 that is! the set o' (etabolic pathways that breaks down (olec%les into s(aller
pieces to release energy. Additionally! scienti'ic research cond%cted on ani(al test s%b)ects deter(ined that
GW501516 has a synergistic e''ect when it is co(bined with AI/AR! or 5A(inoi(ida.ole3carbo+a(ide
ribon%leotide.
Initial Search for Positive Theoretical Benefits with GW50156
4eca%se o' the properties that GW50156 e+hibited! scienti'ic st%dy had concentrated their st%dy on ani(al test
s%b)ects in order to deter(ine i' the peptide co%ld be '%rther researched as a theoretical treat(ent 'or the 'ollowing
ail(ents5
,besity
6iabetes
Click here to buy G 50151! in our store
6yslipide(ia 7that is! an abnor(al a(o%nt o' lipids like cholesterol or 'at in the blood8
/ardio*asc%lar disease! %p to and incl%ding the pre*ention o' cardiac arrest
Additionally! scienti'ic research cond%cted on ani(al test s%b)ects theori.ed that beca%se o' the peptide9s ability to
sti(%late (%scles to b%rn 'ats instead o' s%gars! it co%ld ele*ate le*els o' :good; cholesterol 7that is! <6=
cholesterol8. -his is the cholesterol that helps to red%ce the risk o' cardiac arrest.
GW501516 and Cancer
While scienti'ic research cond%cted on ani(al test s%b)ects had deter(ined several theoretical benefits that (ay
be associated with GW501516! st%dies ha*e yielded res%lts that indicate that these theoretical bene'its are tr%(ped
by the negati*e side e''ects that the peptide ind%ces.
"peci'ically! scienti'ic research cond%cted on ani(al test s%b)ects has deter(ined that GW50156 has the ability to
*ario%s to+icities within the body. "peci'ically! these tests ha*e yielded res%lts that point to the peptide9s capability
to ca%se *ario%s (ani'estations o' cancer in a rapid! e''icient (anner. "cienti'ic st%dy on laboratory test rats had
deter(ined that e+pos%re to the peptide ca%sed se*eral 'or(s o' cancers in the rats! incl%ding5
/ancer o' the skin
/ancer o' the li*er
/ancer o' the bladder
/ancer o' the sto(ach
/ancer o' the thyroid
/ancer o' the tong%e
/ancer o' the testes 7(ale rats only8
/ancer o' the o*aries 7'e(ale rats only8
/ancer o' the wo(b 7'e(ale rats only8
While the scienti'ic st%dy based on ani(al research s%b)ects ha*e ret%rned with research linking GW501516 to the
proli'eration o' cancer! it sho%ld be noted that these tests that res%lted in these types o' associations were based on
large ad(inistrati*e a(o%nts o' the peptide.
For Scientific Use nl!
While there ha*e been se*eral scienti'ic st%dies cond%cted on ani(al test s%b)ects in order to deter(ine
GW5015169s range o' (echanis(s and negati*e side e''ects > especially those related to its association with
cancer > it sho%ld be noted that any and all 'indings that are associated with the peptide are still considered to be
the prod%ct o' c%rrent laboratory research. 4eca%se GW501516 l is c%rrently in the research phase! any st%dy or
%sage relating to the (echanics! operations! and side e''ects o' the peptide sho%ld solely be contained to the
restrictions o' a strictly controlled en*iron(ent s%ch as a library or a (edical research 'acility.

Vous aimerez peut-être aussi